Hyderabad: NATCO Pharma Limited has announced that the U.S. Food and Drug Administration (USFDA) has issued an Establishment ...

Natco Pharma informed that the U.S. Food and Drug Administration (US FDA) has issued an EIR for its active pharmaceutical ingredient (API) division located in Mekaguda, Hyderabad, Telangana.

Natco Pharma has proposed to acquire a 35.75% stake in South African Adcock Ingram Holdings for Rs 2,100 crore. This move ...

The U.S. FDA had inspected the API facility, in Mekaguda here, from June 9-13 and issued Form 483 with one observation. The regulator had classified it as “voluntary action indicated” (VAI), the ...

NATCO Pharma has announced a R4. 2 billion bid to acquire Adcock Ingram, significantly impacting the South African ...

Adcock Ingram offers generics and OTC medicines in Africa. CNBC-Awaaz reported that Natco may buy majority stake in the firm ...

The deal will still see Bidvest as the majority shareholder but will mean that the SA pharmaceutical group will be delisted ...

Hyderabad: NATCO Pharma Limited has submitted a firm intention offer to Adcock Ingram Holdings Limited, a South African ...

Natco Pharma to acquire 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore, marking its entry into the African ...

Natco Pharma to acquire 35.75% stake in South Africa’s Adcock Ingram for ₹1,970 crore in cash; move aimed at expanding global ...

Vice Chairman and CEO Rajeev Nannapaneni said the company is looking for another transaction, potentially as large or even ...

Natco Pharma has made a firm offer to acquire nearly 36% stake in South African drug firm Adcock Ingram Holdings for up to Rs 2,100 crore. This acquisition will provide Natco Pharma with a strong ...